Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection

Vaccine

Volumn 14, Issue 11, 1996, Pages 1062-1068

  Van De Verg, Lillian L ^a   Bendiuk, Natalie O ^a   Kotloff, Karen ^c   Marsh, Michelle M ^a,d   Ruckert, Jennifer L ^a,e   Puryear, Jill L ^a,f   Taylor, David N ^a,g   Hartman, Antoinette B ^a   Oryshkewych, N O ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Ohio EPA   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f APO AA34031 ^*  (United States)

^g California   (Peru)

Author keywords

Antibodies; Cross reactivity; LPS; Shigella flexneri 2a; Vaccine

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; RECOMBINANT VACCINE; SHIGELLA VACCINE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; GUINEA PIG; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; SEROTYPE; SHIGELLA FLEXNERI; VACCINATION;

EID: 0030219969     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00006-0     Document Type: Article

References (29)

1. 1 Ferreccio, C., Prado, V., Ojeda, A. et al. Epidemiological patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago. Chile. Am. J. Epidemiol. 1991, 134, 614
2. 2 Taylor, D.N., Echeverria, P., Pal, T. et al. The role of Shigella spp., enteroinvasive Escherichia coli, and other enteropathogens as causes of childhood dysentery in Thailand. J. Infect. Dis. 1986, 153, 1132
3. 3 Centers for Disease Control (1992). Shigella surveillance reports 1991 and 1992. Atlanta, GA
4. 4 Lee, L.A., Shapiro, C.N., Hargrett-Bean, N. and Tauxe, R.V. Hyperendemic shigellosis in the United States, a review of surveillance data for 1967-1988. J. Infect. Dis. 1991, 164, 894
5. 5 Ekwall, E. and Lindberg, A.A. Shigella flexneri O-antigen-specific enzyme immunoassay: class-specific antibody titres against lipopolysaccharide antigen in adult Swedes with bacillary dysentery. Serodiag. Immunother. Infect. Dis. 1988, 2, 103
6. 6 Munoz, C., Baqar, S., Van De Verg, L. et al. Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances. Am. J. Trop. Med. Hyg. 1995, 53, 47
7. 7 Van De Verg, L.L., Herrington, D.A., Boslego, J., Lindberg, A.A. and Levine, M.M. Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations. J. Infect. Dis. 1992, 166, 158
8. 8 Black, R.E., Levine, M.M., Clements, M.L. et al. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine. J. Infect. Dis. 1987, 155, 1260
9. 9 Kotloff, K.L., Herrington, D.A., Hale, T.L. et al. Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen. Infect. Immun. 1992, 60, 2218
10. 10 Ewing W.H (1986). The genus Shigella. In: Edwards and Ewing's Identification of Enterobacteriaceae. Elsevier Science, New York, pp. 155-166
11. 11 Kenne, L., Lindberg, B., Petersson, K., Katsenellenbogen, E. and Romanowska, E. Structural studies of Shigella flexneri O-antigens. Eur. J. Biochem. 1978, 91, 279
12. 12 Formal, S.B., Oaks, E.V., Olsen, R.E., Wingfield-Eggleston, M., Snoy, P.J. and Cogan, J.P. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei. J. Infect. Dis. 1991, 164, 533
13. 13 Herrington, D.A., Van De Verg, L., Formal, S.B. et al. Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. Vaccine 1990, 8, 353
14. 14 Taylor, D.N., Philip, D.F., Zapor, M. et al. Outpatient studies of the safety and immunogencity of an auxotrophic Escherichia coli K12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2. Vaccine 1994, 12, 565
15. 15 Hartman, A.B., Powell, C.J., Schultz, C.L., Oaks, E.V. and Eckels, K.H. Small animal model to measure efficacy and immunogenicity of Shigella vaccine strains. Infect. Immun. 1991, 59, 4075
16. 16 Formal, S.B., Hale, T.L., Kapfer, C. et al. Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen. Infect. Immun. 1984, 46, 465
17. 17 Newland, J.W., Hale, T.L. and Formal, S.B. Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri 2a hybrid expressing Shigella flexneri 2a somatic antigen. Vaccine 1992, 10, 766
18. 18 Shimada, T. and Sakazaki, R. On the serology of Plesiomonas shigelloides. Jpn J. Med. Sci. Biol. 1978, 31, 135
19. 19 Westphal, O. and Jann, K. Bacterial lipopolysaccharide extraction with phenol:water and further application of the procedure. Meth. Carbohydr. Chem 1965, 5, 82
20. 20 Lindberg, A.A., Ekwall, E. and Carlin, N.I.A. Shigella flexneri O-antigen specific enzyme immunoassay: lipopolysaccharides and synthetic glycoconjugates as antigens. Serodiag. Immunother. 1988, 2, 6
21. 21 Formal S.B., Taylor D.N. and Buysse J.M. Dysentery, bacillary. In: Encyclopedia of Microbiology, vol. 1. Academic Press, San Diego, CA, pp. 1-15.
22. 22 Ekwall, E., Cam, P.D., Chan, N., Phu, L.K., Trach, D.D. and Lindberg, A.A. Shigella flexneri O-antigen specific enzyme immunoassay: a prospective study of class-specific antibody titres against lipopolysaccharide antigens in Vietnamese children and adults with serotype 1b or 2a dysentery. Serodiag. Immunother. Infect. Dis. 1988, 2, 171
23. 23 Kagnoff, M.F. Immunology of the intestinal tract. Gastroent. 1993, 105, 1275
24. 24 Persson, M.A.A., Ekwall, E., Hammarstrom, L., Lindstrom, A.A. and Smith, C.I.E. Immunoglobulin G (IgG) and IgA subclass pattern of human antibodies to Shigella flexneri and Salmonella serogroup B and D lipopolysaccharide O antigens. Infect. Immun. 1986, 52, 834
25. 25 Winsor, D.K., Mathewson, J.J. and DuPont, H.L. Comparison of serum and fecal antibody responses of patients with naturally acquired Shigella sonnei infection. J. Infect. Dis. 1988, 158, 1108
26. 26 Tacket, C.O., Binion, S.B., Bostwick, E., Losonsky, G., Roy, M.J. and Edelman, R. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am. J. Trop. Med. Hyg. 1992, 47, 276
27. 27 Phalipon, A., Michetti, P., Kaufman, M. et al. Protection against invasion of the mouse pulmonary epithelium by a monoclonal IgA directed against Shigella flexneri lipopolysaccharide. Ann. N.Y. Acad. Sci. 1994, 730, 356
28. 28 Mel, D., Gangarosa, E.J., Radovanovic, M.L., Arsic, B.L. and Litvinjenko, S. Studies on vaccination against bacillary dysentery 6. protection of children by oral immunization with streptomycin-dependent Shigella strains. Bull. WHO 1971, 45, 457
29. 29 Karnell, A., Sweiha, H. and Lindberg, A.A. Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes. Vaccine 1992, 10, 167